BMI is a 200-year-old formula that cannot tell fat from muscle. Fat Mass Index (FMI) measures your actual body fat scaled to your height, and recent NHANES data shows it predicts mortality far more accurately than BMI. If you only ever look at one obesity metric on your DEXA scan report, this is the one to learn.
Find a DEXASCAN.com clinic near you →
What Is Fat Mass Index (FMI)?
Fat Mass Index, or FMI, is the kilograms of fat on your body divided by your height in meters squared. It is reported in kg/m² — the same units as BMI — but unlike BMI, it measures fat specifically, not total body weight.
The formula:
FMI = Total Fat Mass (kg) ÷ Height² (m²)
Where BMI lumps together fat, muscle, bone, organ tissue, and water and divides that single number by height squared, FMI isolates just the adipose tissue. That distinction matters more than almost any other number on a body composition report, because fat tissue, not body weight, is what actually drives metabolic disease, cardiovascular risk, and mortality.
FMI is one of the headline metrics on every whole-body DEXA scan report at a DEXASCAN.com certified clinic. It is also the metric the medical literature is increasingly converging on as the replacement for BMI in clinical risk stratification.
How FMI Is Calculated From a DEXA Scan
A whole-body dual-energy X-ray absorptiometry (DEXA) scan splits your body into three compartments — fat, lean soft tissue, and bone — region by region. The scanner uses two low-dose X-ray energies that are attenuated differently by each tissue type, allowing precise separation of fat mass from everything else.
That precision is the entire point. DEXA quantifies body fat with a 1–2% margin of error — orders of magnitude tighter than what you can get from a tape measure, a smart scale, or a calculation based on height and weight.[^1]
Once the scanner reports your total fat mass in kilograms, dividing by your height squared produces FMI:
| Example | Height | Weight | Fat mass | FMI |
|---|---|---|---|---|
| Adult A | 1.78 m | 80 kg | 14 kg | 4.4 kg/m² |
| Adult B | 1.78 m | 80 kg | 26 kg | 8.2 kg/m² |
Same height. Same weight. Same BMI (25.2). Different bodies. Different futures.
That gap is the single most important reason FMI exists.
FMI vs BMI: The Difference That Actually Matters
BMI was originally developed in the 1830s by Belgian mathematician Adolphe Quetelet as a way to describe population averages. It was never designed as an individual clinical tool. Yet today it is the obesity metric used by virtually every primary care office, insurance company, and employer wellness program in the United States.
The structural problem with BMI is simple: it cannot distinguish a kilogram of fat from a kilogram of muscle. A 200-pound powerlifter and a 200-pound sedentary office worker at the same height have an identical BMI and radically different health profiles. A 130-pound woman with very low muscle mass and a high body fat percentage — what researchers call "normal weight obesity" — has a normal BMI and a metabolic profile that looks more like the obese category.
The data on this is no longer subtle. A 2025 study published in the Annals of Family Medicine tracked 4,252 U.S. adults aged 20–49 from NHANES data over 15 years and reported that:
- BMI was "entirely unreliable" in predicting 15-year all-cause mortality
- Body fat percentage was a "far more accurate" predictor
- Adults with high body fat were 78% more likely to die during the 15-year follow-up than those with healthy body fat
- High body fat was associated with more than triple the risk of dying from heart disease
The senior author, Dr. Frank Orlando at University of Florida Health, concluded that BMI "should not be relied upon as a vital sign of health."[^2][^3]
A separate large-scale Taiwanese cohort study following 1,200 adults over a mean of 5.9 years found that FMI was a positive predictor of mortality in women, while BMI alone did not capture the same signal. Skeletal muscle mass index and fat mass index together outperformed BMI as predictors of all-cause mortality, particularly in adults over 65.[^4]
Even the American Heart Association, in a scientific statement on identifying obesity and cardiovascular risk in diverse populations, acknowledged that BMI with standard thresholds provides a poor estimate of adiposity across racial and ethnic groups — and that the same BMI value corresponds to widely different body fat percentages depending on age, sex, and ethnicity.[^5]
In short: BMI is a screening shortcut. FMI is the actual measurement.
What Is a "Normal" FMI? The Research-Backed Reference Ranges
Unlike BMI, FMI has gender-specific reference ranges that reflect the genuinely different healthy fat distributions in men and women. Here are the most commonly cited thresholds, drawn from NHANES DXA data and the widely used Kelly et al. classification:
FMI categories for adult men
| Category | FMI (kg/m²) |
|---|---|
| Underfat | < 3 |
| Healthy range | 3 – 6 |
| Overweight | 6 – 9 |
| Obese | ≥ 9 |
FMI categories for adult women
| Category | FMI (kg/m²) |
|---|---|
| Underfat | < 5 |
| Healthy range | 5 – 9 |
| Overweight | 9 – 13 |
| Obese | ≥ 13 |
These thresholds, originally derived from NHANES whole-body DEXA reference data, are the de facto standard used by most clinical DEXA reporting software in North America.[^6][^1]
Age matters: FMI rises naturally with age
Reference values from large European DEXA cohorts confirm that FMI increases with age in both sexes. In the Italian DEXA reference dataset of 1,866 healthy adults aged 20–80, FMI in men rose from a reference range of 2.9–4.8 kg/m² in the 20–29 age bracket to 5.6–8.6 kg/m² in the 70–80 bracket, with similar age-related increases in women.[^7]
This is normal biology — but the practical implication is that an FMI that was healthy at 30 may be borderline at 60 if you have not actively maintained body composition. The only way to know where you actually sit is to measure.
Clinical FMI cutoffs for metabolic and cardiovascular risk
A cross-sectional study of 616 adults at a preventive medicine center used ROC curve analysis to identify FMI thresholds predictive of poor metabolic and cardiovascular outcomes. The cutoffs identified were:
- Metabolic health risk: FMI ≥ 5.5 kg/m² (both men and women)
- Cardiovascular complications: FMI ≥ 7.0 kg/m² (men), ≥ 6.4 kg/m² (women)
In the same analysis, BMI thresholds for the same outcomes were generally below the conventional 25 kg/m² cutoff — meaning standard BMI categories were systematically under-flagging people at metabolic and cardiovascular risk.[^8]
Get your FMI measured on a DEXASCAN.com whole-body scan →
Why High FMI Matters: The Health Risks BMI Misses
Excess fat tissue is not biologically inert. It is metabolically active, hormonally active, and inflammatory. High FMI — especially when accompanied by elevated visceral adipose tissue — is a well-established driver of:
Cardiovascular disease
A 2025 NHANES analysis of 45,000 adults found that participants in the highest relative fat mass quartile had a 2.11-fold increased risk of cardiovascular disease compared to those in the lowest quartile, with the association strongest in adults under 60.[^9]
Type 2 diabetes and metabolic syndrome
Fat Mass Index has been shown to outperform both BMI and body fat percentage in screening for metabolic syndrome. Adipose tissue, particularly visceral adipose tissue, drives insulin resistance through chronic low-grade inflammation and altered adipokine signaling.[^10]
Hypertension and dyslipidemia
Adipose tissue secretes inflammatory cytokines (TNF-α, IL-6) and dysregulates the renin-angiotensin system, both contributing to blood pressure elevation and lipid abnormalities — effects that scale with FMI more reliably than with BMI.
All-cause and cancer mortality
The 2025 Annals of Family Medicine analysis cited above showed that adults with high body fat had a 78% higher risk of dying over 15 years than those with healthy body fat, and significantly elevated cancer and cardiovascular mortality.[^2]
Normal-weight obesity: the hidden risk
Perhaps the most clinically important contribution of FMI is its ability to identify "normal-weight obesity" — adults with a BMI in the normal range (18.5–24.9) but a fat mass index in the overweight or obese category. These individuals carry cardiovascular and metabolic risk profiles that look nothing like what their BMI suggests, and they are routinely missed by BMI-based screening.[^11]
FMI Plus Visceral Fat: The Two-Number Picture
FMI tells you how much fat you carry. Visceral adipose tissue (VAT) — also measured on a DEXA scan — tells you where the most dangerous fat lives: deep inside the abdomen, surrounding the liver, pancreas, and intestines.
A 2025 NHANES-based study established sex-specific VAT thresholds for cardiovascular disease risk stratification:
- Men: VAT volume threshold of 387.5 cm³
- Women: VAT volume threshold of 312.0 cm³
The authors noted that BMI "fails to capture critical pathophysiological distinctions in regional adiposity deposition, conflating lean mass with fat mass and disregarding visceral adipose tissue distribution patterns."[^12]
This is exactly why a whole-body DEXA scan is more informative than any blood test, scale, or measurement protocol you can run in a primary care office. In a single 7–10 minute scan, you get both FMI and VAT — the quantity and the distribution of fat — along with your appendicular lean mass index (ALMI) and bone mineral density.
If you want to see why ALMI is the muscle metric to pair with FMI, read our companion guide: Appendicular Lean Mass Index (ALMI): The DEXA Scan Number That Predicts How Well You'll Age.
FMI in the GLP-1 Era: Why You Need a Baseline Before You Start
The fastest-growing audience for body composition testing in 2026 is people on GLP-1 and dual incretin medications — semaglutide, tirzepatide, and the new generation behind them. These drugs produce substantial weight loss, but the scale weight cannot tell you what kind of weight is leaving your body.
Recent body composition research published in Cell Reports Medicine confirmed that GLP-1 receptor agonists produce a preferential reduction of fat mass over lean body mass — a good outcome — but the lean mass loss is not zero. Without measurement, you cannot tell whether your weight loss is the kind you actually want.[^13]
A pre-GLP-1 DEXA scan gives you three numbers that matter on this journey:
- Starting FMI — so you know how much fat you actually need to lose
- Starting ALMI — so you know how much muscle you need to protect
- Starting VAT — so you can verify the metabolically dangerous fat is going down, not just total weight
Three months in, a repeat scan tells you whether your protocol is working. If your FMI is dropping and your ALMI is holding, the drug is doing exactly what you want. If both are dropping in parallel, you need to immediately add resistance training and raise protein intake.
This is exactly the kind of data the scale will never give you.
How to Lower Your FMI: What the Evidence Actually Supports
Reducing FMI requires reducing fat mass without sacrificing muscle. The evidence-based interventions are:
1. Sustained caloric deficit with adequate protein
A modest caloric deficit (typically 300–500 calories/day) combined with 1.2–1.6 g/kg/day of protein preserves lean mass while reducing fat mass. Protein distribution across 3–4 meals optimizes per-meal muscle protein synthesis.
2. Resistance training, 2–4 sessions per week
Resistance training is the single most powerful tool for ensuring that weight lost during a deficit is predominantly fat rather than muscle. It also improves insulin sensitivity independent of weight change.
3. Aerobic exercise
Adds to caloric expenditure, improves cardiovascular fitness, and produces modest additional fat loss when combined with resistance work and a caloric deficit. Not a replacement for resistance training.
4. Sleep and stress management
Insufficient sleep (chronic <7 hours) and chronic stress both drive cortisol elevation, which is associated with visceral fat accumulation independent of caloric intake.
5. Periodic DEXA monitoring
Every 3–6 months during active fat loss. Tracking the trend of FMI and ALMI together is what tells you whether your protocol is working, well before your weight or your mirror does.
Book a follow-up DEXA scan to track your FMI trend →
Tracking Fat Loss Between DEXA Scans With an At-Home Body Composition Scale
A DEXA scan every 3 months is the right cadence for clinical-grade FMI decisions during active fat loss. But fat mass shifts week to week — and during weight loss, recomposition, or any structured intervention, you need a way to see whether fat is actually coming off between your scans, or whether scale-weight changes are just water and glycogen fluctuations.
This is where an at-home body composition scale becomes the essential complement to your DEXA scans.
Why FMI is the most natural metric to track with an at-home scale
Of all the body composition metrics on a DEXA report, fat mass percentage is the one that bioelectrical impedance (BIA) scales track most reliably. BIA is less accurate than DEXA for absolute values, but for directional change in fat mass over weeks and months — measured on the same scale, under consistent conditions — it produces genuinely useful trend data.
A 28% body fat reading on your scale may not be exactly the same as the 26.4% your DEXA scan reports — but if your scale shows you dropping from 28% to 25% over 12 weeks, that 3-point downward trend is real. The relative change is reliable even when the absolute number is not perfectly calibrated.
This is the same principle that makes home blood pressure cuffs useful: the cuff may read slightly differently than the clinic device, but the trend on your own monitor tells you whether your intervention is working.
What an at-home scale can show you between FMI scans
- Total body fat percentage trend — directional movement between DEXA scans
- Body water shifts — which can produce misleading scale-weight changes that are not actually fat loss
- Lean mass holding or trending down — verifying that fat loss is not coming with disproportionate muscle loss
- Segmental fat distribution — left vs. right and upper vs. lower body, useful for tracking fat redistribution
- Visceral fat estimate — less accurate than DEXA but useful for trending the most dangerous fat depot
Why this matters during active fat loss specifically
Fat loss is non-linear. Some weeks the scale moves 2–3 pounds. Some weeks it does not move. Some weeks it moves up despite a continued caloric deficit, because of water retention, sodium shifts, or normal physiological fluctuation. Without between-scan data, it is nearly impossible to tell whether:
- A "stall" is real fat-loss stagnation or just a hydration artifact
- Your scale-weight gain this week is fat regain or water retention
- The protein and training adjustments you made are actually preserving lean mass
- You need to push for a more aggressive intervention or stay the course
An at-home scale gives you that signal every few days — so by the time your next DEXA scan arrives, you already have a working hypothesis about what you will find, and you have not lost weeks of potential course corrections waiting for the clinical scan.
How to use an at-home scale correctly for FMI trend tracking
Accuracy of BIA depends almost entirely on measurement consistency:
- Same time of day — first thing in the morning, after using the bathroom, before eating or drinking, is the most reproducible window
- Same hydration state — significant dehydration or fluid overload will shift readings independent of any real fat change
- Same scale, always — different devices produce systematically different absolute values
- Bare feet, dry skin, hard flooring — not carpet
- Track the rolling 7-day or 14-day average, not daily readings — daily fluctuation is dominated by water; weekly averages reveal the real trend
- Anchor to your DEXA scan — note your scale's reading on the day of your DEXA scan, so you know the offset between your scale and clinical reality
The DEXA+ Body Fat Scale: built for between-scan FMI tracking
The DEXA+ Body Fat Scale uses 8-electrode segmental BIA — substantially more accurate than typical 2- or 4-electrode bathroom scales — and integrates directly with the DEXA Scan app so your at-home body fat percentage readings and your in-clinic DEXA FMI results appear in the same trend chart on the same timeline.
For adults actively working on fat loss, recomposition, or any structured nutritional intervention, the combination of a DEXA scan every 3–6 months plus consistent at-home trend tracking is the right feedback loop. The DEXA scan gives you the source-of-truth reference points. The scale fills the gap in between.
Learn more about the DEXA+ Body Fat Scale →
Why a DEXA Scan Is the Only Reliable Way to Measure FMI
Several methods claim to measure body fat. Only one of them is suitable for tracking a metric as clinically important as FMI:
| Method | Accuracy | Reproducibility | Regional data |
|---|---|---|---|
| BMI | Poor — cannot distinguish fat from muscle | High | None |
| Bathroom scale BIA | Modest for absolute values, useful for trending | Moderate | Limited |
| Skinfold calipers | Operator-dependent | Low | Limited |
| Hydrostatic weighing | Good | Moderate | None |
| DEXA scan | 1–2% margin of error | Excellent | Full regional breakdown |
| MRI / CT | Excellent | Excellent | Excellent (but high cost, limited access) |
A whole-body DEXA scan at a DEXASCAN.com network clinic delivers clinical-grade fat mass measurement plus visceral adipose tissue quantification plus regional lean mass plus bone mineral density — in a single 7–10 minute appointment, with radiation exposure equivalent to a few hours of natural background radiation.
There are roughly 300 DEXASCAN.com partner clinics across the United States, all using standardized clinical scanners and reporting so your scans remain directly comparable across visits. That comparability is what makes FMI trending — not just single-point measurement — actually possible.
Track Your FMI in the DEXA Scan App
A single FMI number is a starting point. A long-term FMI trend is what changes outcomes. Fat mass shifts slowly. Visceral fat shifts even more slowly. The signal you are looking for is direction over months, not noise over days.
The free DEXA Scan app, available on iOS and Android, lets you:
- Store every DEXA scan in one place
- Visualize your FMI, VAT, body fat %, ALMI, and bone density trends over time
- Compare your numbers to age- and sex-matched reference ranges
- Receive evidence-based recommendations tied to your specific results
- Book your next scan at any DEXASCAN.com network clinic
Frequently Asked Questions About Fat Mass Index
What is a healthy FMI?
For adult men, the healthy FMI range is approximately 3–6 kg/m². For adult women, the healthy range is approximately 5–9 kg/m². FMI ≥ 9 kg/m² in men or ≥ 13 kg/m² in women is generally classified as obesity.[^6]
Is FMI more accurate than BMI?
Yes, for assessing actual body fat. BMI cannot distinguish fat from muscle and significantly misclassifies athletic individuals, older adults, and people with "normal-weight obesity." Recent NHANES analyses show that direct fat measurement predicts mortality more accurately than BMI in adults under 50.[^2]
Can a smart scale give me an accurate FMI?
Not for clinical-grade accuracy or formal diagnosis. Bioelectrical impedance scales estimate fat mass using equations and are sensitive to hydration, food intake, and device-specific algorithms. However, a quality at-home scale used consistently (same time of day, same conditions) is excellent for tracking trends in body fat percentage between DEXA scans. The right model: DEXA every 3–6 months as your clinical reference standard, an 8-electrode segmental scale like the DEXA+ Body Fat Scale for between-scan trend tracking.[^14]
How often should I get a DEXA scan to track my FMI?
For most adults, every 3 months is appropriate. For people actively losing weight, starting a GLP-1 medication, or undergoing a structured training program, every 3–4 months is reasonable to detect early trends.
What is "normal-weight obesity"?
A person with a BMI in the normal range (18.5–24.9 kg/m²) but a fat mass index in the overweight or obese range. These individuals carry elevated cardiovascular and metabolic risk that is invisible to BMI-based screening and only becomes visible on a body composition scan.[^11]
Does FMI replace BMI in clinical practice?
Not yet officially, but the evidence base is building rapidly. The American Heart Association has already acknowledged BMI's limitations across diverse populations, and recent mortality data is pushing the field toward direct fat measurement as the preferred risk stratification metric.[^5][^2]
The Bottom Line
BMI tells you what you weigh relative to your height. Fat Mass Index tells you how much of that weight is the part that matters.
If you have a DEXA scan report, your FMI is already calculated for you. If you do not, the next step is simple.
Find a DEXASCAN.com clinic near you and book your whole-body scan →
Download the DEXA Scan app to track your FMI trend →
Read next: Appendicular Lean Mass Index (ALMI): The DEXA Scan Number That Predicts How Well You'll Age
References
[^1]: Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS ONE. 2009. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737140/
[^2]: Smith ME, Bhupathiraju SN, Orlando F, et al. Body Mass Index vs Body Fat Percentage as a Predictor of Mortality in Adults Aged 20-49 Years. Annals of Family Medicine. 2025;23(4):337. Available at: https://www.annfammed.org/content/23/4/337.full
[^3]: University of Florida Health press release on BMI vs body fat percentage as mortality predictors. 2025. Available at: https://www.foxnews.com/health/body-fat-predicts-major-health-risk-bmi-misses-researchers-say.amp
[^4]: Liao CD, Tsauo JY, Wu YT, et al. Effects of age and gender on body composition indices as predictors of mortality in middle-aged and old people. Scientific Reports. 2022. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098413/
[^5]: Carroll JF, Chiapa AL, Rodriquez M, et al. Identification of Obesity and Cardiovascular Risk in Ethnically and Racially Diverse Populations: AHA Scientific Statement. Circulation. 2015. Available at: https://www.ahajournals.org/doi/10.1161/cir.0000000000000223
[^6]: Levels Health. What you can learn from a DEXA scan: FMI classification thresholds. 2025. Available at: https://www.levels.com/blog/what-you-can-learn-from-dexa-scan
[^7]: Coin A, Sergi G, Minicuci N, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20–80 year-old Italian population. Clinical Nutrition. 2008;27(1):87–94. Available at: https://pubmed.ncbi.nlm.nih.gov/18206273/
[^8]: Liu P, Ma F, Lou H, Liu Y. Determination of Cutoff Values for DEXA-Based Body Composition Measurements for Determining Metabolic and Cardiovascular Health. BioMed Research International. 2013. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497664/
[^9]: Association between relative fat mass and cardiovascular disease: a cross-sectional study based on NHANES. Frontiers in Cardiovascular Medicine. 2025. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12234565/
[^10]: Liu P, Ma F, Lou H, Liu Y. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013. Available at: https://pubmed.ncbi.nlm.nih.gov/23819808/
[^11]: Comparative Analysis of Surrogate Adiposity Markers and Their Relationship With Mortality. medRxiv preprint. 2022. Available at: https://www.medrxiv.org/content/10.1101/2022.09.26.22280347.full.pdf
[^12]: Visceral Adiposity Thresholds for Cardiovascular Risk Stratification: A Simplified Biomarker-Driven Model. Obesity. 2025. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477109/
[^13]: Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans. Cell Reports Medicine. 2026. Available at: https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00082-0
[^14]: Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA in adults aged 18–81 years — results from the LEAD cohort. European Journal of Clinical Nutrition. 2020. Available at: https://www.nature.com/articles/s41430-020-0596-5
Medical disclaimer: This article is for educational purposes and does not constitute medical advice. Body composition interpretation and clinical decisions should be made in partnership with your physician. DEXASCAN.com clinics provide body composition measurement; clinical interpretation should be conducted with a qualified healthcare provider.
©All rights reserved. DEXASCAN.com — the national network for whole-body DEXA scanning.